Cloning and characterization of rhesus IL-18 binding protein, a natural antagonist to IL-18

Cytokine

Volumn 51, Issue 3, 2010, Pages 232-239

  Yellayi, Srikanth ^a   Braun, Steve ^a   Domingues, Heber G ^a   Kityatana, Nadya ^b   Murali, Ramachandran ^b   Johnson, R Paul ^a   Mansfield, Keith ^a   Westmoreland, Susan V ^a   O'Neil, Shawn P ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Atherosclerosis; IL 18; IL 18 binding protein; IL 18BP; Macaque

Indexed keywords

COMPLEMENTARY DNA; FC RECEPTOR; GAMMA INTERFERON; GLYCOPROTEIN; IMMUNOGLOBULIN G1; INTERLEUKIN 18; INTERLEUKIN 18 BINDING PROTEIN; LIPOPOLYSACCHARIDE; HYBRID PROTEIN; IMMUNOGLOBULIN G; INTERLEUKIN-18 BINDING PROTEIN; SIGNAL PEPTIDE;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; CYTOCHEMISTRY; CYTOKINE PRODUCTION; DISEASE MODEL; DNA SEQUENCE; FEMALE; FOAM CELL; HISTOPATHOLOGY; HOST RESISTANCE; IMMUNE RESPONSE; MOLECULAR CLONING; MOLECULAR WEIGHT; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; ORTHOLOGY; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RHESUS MONKEY; SEQUENCE ANALYSIS; SPECIES DIFFERENCE; SPLEEN CELL; TH1 CELL; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; MOLECULAR GENETICS; PROTEIN TRANSPORT; SPLEEN;

MACACA MULATTA; MURINAE;

AMINO ACID SEQUENCE; ANIMALS; ATHEROSCLEROSIS; BASE SEQUENCE; CLONING, MOLECULAR; HUMANS; IMMUNOGLOBULIN G; IMMUNOHISTOCHEMISTRY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERFERON-GAMMA; INTERLEUKIN-18; LIPOPOLYSACCHARIDES; MACACA MULATTA; MICE; MOLECULAR SEQUENCE DATA; MOLECULAR WEIGHT; PROTEIN TRANSPORT; RECOMBINANT FUSION PROTEINS; SEQUENCE ANALYSIS, PROTEIN; SPLEEN;

EID: 77955279570     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2010.05.010     Document Type: Article

References (52)

1. Nakamura K., Okamura H., Nagata K., Komatsu T., Tamura T. Purification of a factor which provides a costimulatory signal for gamma interferon production. Infect Immun 1993, 61:64-70.
2. Gu Y., Kuida K., Tsutsui H., Ku G., Hsiao K., Fleming M.A., et al. Activation of interferon-gamma inducing factor mediated by interleukin-1beta converting enzyme. Science 1997, 275:206-209.
3. Ghayur T., Banerjee S., Hugunin M., Butler D., Herzog L., Carter A., et al. Caspase-1 processes IFN-gamma-inducing factor and regulates LPS-induced IFN-gamma production. Nature 1997, 386:619-623.
4. Dinarello C.A., Fantuzzi G. Interleukin-18 and host defense against infection. J Infect Dis 2003, 187(Suppl. 2):S370-S384.
5. Okamura H., Tsutsi H., Komatsu T., Yutsudo M., Hakura A., Tanimoto T., et al. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 1995, 378:88-91.
6. Novick D., Kim S.H., Fantuzzi G., Reznikov L.L., Dinarello C.A., Rubinstein M. Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response. Immunity 1999, 10:127-136.
7. Xiang Y., Moss B. IL-18 binding and inhibition of interferon gamma induction by human poxvirus-encoded proteins. Proc Natl Acad Sci USA 1999, 96:11537-11542.
8. Born T.L., Morrison L.A., Esteban D.J., VandenBos T., Thebeau L.G., Chen N., et al. A poxvirus protein that binds to and inactivates IL-18, and inhibits NK cell response. J Immunol 2000, 164:3246-3254.
9. Smith V.P., Bryant N.A., Alcami A. Ectromelia, vaccinia and cowpox viruses encode secreted interleukin-18-binding proteins. J Gen Virol 2000, 81:1223-1230.
10. Calderara S., Xiang Y., Moss B. Orthopoxvirus IL-18 binding proteins: affinities and antagonist activities. Virology 2001, 279:22-26.
11. Muhl H., Kampfer H., Bosmann M., Frank S., Radeke H., Pfeilschifter J. Interferon-gamma mediates gene expression of IL-18 binding protein in nonleukocytic cells. Biochem Biophys Res Commun 2000, 267:960-963.
12. Paulukat J., Bosmann M., Nold M., Garkisch S., Kampfer H., Frank S., et al. Expression and release of IL-18 binding protein in response to IFN-gamma. J Immunol 2001, 167:7038-7043.
13. Hurgin V., Novick D., Rubinstein M. The promoter of IL-18 binding protein: activation by an IFN-gamma-induced complex of IFN regulatory factor 1 and CCAAT/enhancer binding protein beta. Proc Natl Acad Sci USA 2002, 99:16957-16962.
14. Faggioni R., Cattley R.C., Guo J., Flores S., Brown H., Qi M., et al. IL-18-binding protein protects against lipopolysaccharide- induced lethality and prevents the development of Fas/Fas ligand-mediated models of liver disease in mice. J Immunol 2001, 167:5913-5920.
15. Banda N.K., Vondracek A., Kraus D., Dinarello C.A., Kim S.H., Bendele A., et al. Mechanisms of inhibition of collagen-induced arthritis by murine IL-18 binding protein. J Immunol 2003, 170:2100-2105.
16. Novick D., Elbirt D., Dinarello C.A., Rubinstein M., Sthoeger Z.M. Interleukin-18 binding protein in the sera of patients with Wegener's granulomatosis. J Clin Immunol 2009, 29:38-45.
17. Kim S.H., Eisenstein M., Reznikov L., Fantuzzi G., Novick D., Rubinstein M., et al. Structural requirements of six naturally occurring isoforms of the IL-18 binding protein to inhibit IL-18. Proc Natl Acad Sci USA 2000, 97:1190-1195.
18. Mallat Z., Corbaz A., Scoazec A., Graber P., Alouani S., Esposito B., et al. Interleukin-18/interleukin-18 binding protein signaling modulates atherosclerotic lesion development and stability. Circ Res 2001, 89:E41-E45.
19. Hulthe J., McPheat W., Samnegard A., Tornvall P., Hamsten A., Eriksson P. Plasma interleukin (IL)-18 concentrations is elevated in patients with previous myocardial infarction and related to severity of coronary atherosclerosis independently of C-reactive protein and IL-6. Atherosclerosis 2006, 188:450-454.
20. Ludwiczek O., Kaser A., Novick D., Dinarello C.A., Rubinstein M., Vogel W., et al. Plasma levels of interleukin-18 and interleukin-18 binding protein are elevated in patients with chronic liver disease. J Clin Immunol 2002, 22:331-337.
21. Moller B., Nguyen T.T., Kessler U., Kaltwasser J.P., Hoelzer D., Ottmann O.G. Interleukin-10 expression: is there a neglected contribution of CD8+ T cells in rheumatoid arthritis joints?. Clin Exp Rheumatol 2002, 20:813-822.
22. Jander S., Stoll G. Differential induction of interleukin-12, interleukin-18, and interleukin-1beta converting enzyme mRNA in experimental autoimmune encephalomyelitis of the Lewis rat. J Neuroimmunol 1998, 91:93-99.
23. Balashov K.E., Rottman J.B., Weiner H.L., Hancock W.W. CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions. Proc Natl Acad Sci USA 1999, 96:6873-6878.
24. Corbaz A., ten Hove T., Herren S., Graber P., Schwartsburd B., Belzer I., et al. IL-18-binding protein expression by endothelial cells and macrophages is up-regulated during active Crohn's disease. J Immunol 2002, 168:3608-3616.
25. Joosten L.A., van De Loo F.A., Lubberts E., Helsen M.M., Netea M.G., van Der Meer J.W., et al. An IFN-gamma-independent proinflammatory role of IL-18 in murine streptococcal cell wall arthritis. J Immunol 2000, 165:6553-6558.
26. Blankenberg S., Tiret L., Bickel C., Peetz D., Cambien F., Meyer J., et al. Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina. Circulation 2002, 106:24-30.
27. Thompson S.R., Novick D., Stock C.J., Sanders J., Brull D., Cooper J., et al. Free Interleukin (IL)-18 levels, and the impact of IL18 and IL18BP genetic variation, in CHD patients and healthy men. Arterioscler Thromb Vasc Biol 2007, 27:2743-2749.
28. Yamagami H., Kitagawa K., Hoshi T., Furukado S., Hougaku H., Nagai Y., et al. Associations of serum IL-18 levels with carotid intima-media thickness. Arterioscler Thromb Vasc Biol 2005, 25:1458-1462.
29. Gerdes N., Sukhova G.K., Libby P., Reynolds R.S., Young J.L., Schonbeck U. Expression of interleukin (IL)-18 and functional IL-18 receptor on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for atherogenesis. J Exp Med 2002, 195:245-257.
30. Mallat Z., Corbaz A., Scoazec A., Besnard S., Leseche G., Chvatchko Y., et al. Expression of interleukin-18 in human atherosclerotic plaques and relation to plaque instability. Circulation 2001, 104:1598-1603.
31. Whitman S.C., Ravisankar P., Daugherty A. Interleukin-18 enhances atherosclerosis in apolipoprotein E(-/-) mice through release of interferon-gamma. Circ Res 2002, 90:E34-E38.
32. Elhage R., Jawien J., Rudling M., Ljunggren H.G., Takeda K., Akira S., et al. Reduced atherosclerosis in interleukin-18 deficient apolipoprotein E-knockout mice. Cardiovasc Res 2003, 59:234-240.
33. Tabib A., Greenland T., Mercier I., Loire R., Mornex J.F. Coronary lesions in young HIV-positive subjects at necropsy. Lancet 1992, 340:730.
34. Paton P., Tabib A., Loire R., Tete R. Coronary artery lesions and human immunodeficiency virus infection. Res Virol 1993, 144:225-231.
35. Passalaris J.D., Sepkowitz K.A., Glesby M.J. Coronary artery disease and human immunodeficiency virus infection. Clin Infect Dis 2000, 31:787-797.
36. Lorenz M.W., Stephan C., Harmjanz A., Staszewski S., Buehler A., Bickel M., et al. Both long-term HIV infection and highly active antiretroviral therapy are independent risk factors for early carotid atherosclerosis. Atherosclerosis 2008, 196:720-726.
37. Grunfeld C., Feingold K.R. The role of the cytokines, interferon alpha and tumor necrosis factor in the hypertriglyceridemia and wasting of AIDs. J Nutr 1992, 122:749-753.
38. Feingold K.R., Krauss R.M., Pang M., Doerrler W., Jensen P., Grunfeld C. The hypertriglyceridemia of acquired immunodeficiency syndrome is associated with an increased prevalence of low density lipoprotein subclass pattern B. J Clin Endocrinol Metab 1993, 76:1423-1427.
39. Yearley J.H., Xia D., Pearson C.B., Carville A., Shannon R.P., Mansfield K.G. Interleukin-18 predicts atherosclerosis progression in SIV-infected and uninfected rhesus monkeys (Macaca mulatta) on a high-fat/high-cholesterol diet. Lab Invest 2009, 89:657-667.
40. Huang J.H., Tykocinski M.L. CTLA-4-Fas ligand functions as a trans signal converter protein in bridging antigen-presenting cells and T cells. Int Immunol 2001, 13:529-539.
41. Krumm B., Meng X., Li Y., Xiang Y., Deng J. Structural basis for antagonism of human interleukin 18 by poxvirus interleukin 18-binding protein. Proc Natl Acad Sci USA 2008, 105:20711-20715.
42. Kimura T., Kato Z., Ohnishi H., Tochio H., Shirakawa M., Kondo N. Expression, purification and structural analysis of human IL-18 binding protein: a potent therapeutic molecule for allergy. Allergol Int 2008, 57:367-376.
43. Marti-Renom M.A., Stuart A.C., Fiser A., Sanchez R., Melo F., Sali A. Comparative protein structure modeling of genes and genomes. Annu Rev Biophys Biomol Struct 2000, 29:291-325.
44. Van Snick J., De Plaen E., Boon T. A neomycin-resistant cell line for improved production of monoclonal antibodies to cell surface antigens. Eur J Immunol 1985, 15:1151-1153.
45. Xiang Y., Moss B. Determination of the functional epitopes of human interleukin-18-binding protein by site-directed mutagenesis. J Biol Chem 2001, 276:17380-17386.
46. Xiang Y., Moss B. Correspondence of the functional epitopes of poxvirus and human interleukin-18-binding proteins. J Virol 2001, 75:9947-9954.
47. Meng X., Leman M., Xiang Y. Variola virus IL-18 binding protein interacts with three human IL-18 residues that are part of a binding site for human IL-18 receptor alpha subunit. Virology 2007, 358:211-220.
48. Blankenberg S., Luc G., Ducimetiere P., Arveiler D., Ferrieres J., Amouyel P., et al. Interleukin-18 and the risk of coronary heart disease in European men: the Prospective Epidemiological Study of Myocardial Infarction (PRIME). Circulation 2003, 108:2453-2459.
49. Tiret L., Godefroy T., Lubos E., Nicaud V., Tregouet D.A., Barbaux S., et al. Genetic analysis of the interleukin-18 system highlights the role of the interleukin-18 gene in cardiovascular disease. Circulation 2005, 112:643-650.
50. Espinola-Klein C., Rupprecht H.J., Bickel C., Lackner K., Schnabel R., Munzel T., et al. Inflammation, atherosclerotic burden and cardiovascular prognosis. Atherosclerosis 2007, 195:e126-e134.
51. Mansfield K.G., Carville A., Wachtman L., Goldin B.R., Yearley J., Li W., et al. A diet high in saturated fat and cholesterol accelerates simian immunodeficiency virus disease progression. J Infect Dis 2007, 196:1202-1210.
52. Schif-Zuck S., Westermann J., Netzer N., Zohar Y., Meiron M., Wildbaum G., et al. Targeted overexpression of IL-18 binding protein at the central nervous system overrides flexibility in functional polarization of antigen-specific Th2 cells. J Immunol 2005, 174:4307-4315.